tirzepatide surpass-5 Significantly Reduced A1C and Body Weight in People with Type 2 Diabetes in Two Phase 3 Trials from Lilly's SURPASS Program-CliniExpert Zepbound Tirzepatide Injection 5 mg/0.5

In February 2024, Castor announced a partnership with Microsoft to utilize Azure and advanced AI technologies in their clinical trial platforms

Can I restart after surgery

We currently intend to use the net proceeds from this offering and the concurrent private placement, together with our existing cash and cash equivalents as follows: Based on our current operating plan, we believe that our existing cash and cash equivalents, together with the net proceeds from this offering, will be sufficient for us to fund our operations into 2029

Associations of trimethylamine N-oxide with nutritional and inflammatory biomarkers and cardiovascular outcomes in patients new to dialysis

361-3E), in 85% to 100% of Asian neonates, more than 60% of black neonates, and less than 10% of white neonates

Keep your injection supplies in a sealed pouch to maintain hygiene